Neumora Therapeutics, Inc. Common Stock (NMRA) News

Latest headlines that mention NMRA, newest first · each headline opens the original publisher

NMRA quote

Last price: $0.42
Day change: -10.54%
Next earnings: 2026-11-05

Quote & chart Expected move Insider trading IV rank history

NMRA headlines

latest coverage

Not much coverage yet. NMRA has appeared in only a few headlines lately; new stories show up here as publishers cover it.

Investing.com 2mo ago

Neumora Therapeutics COO Aurora disposes of $269,966 in stock

General T3NMRA

Investing.com 2mo ago

Neumora Therapeutics COO Daljit Aurora sells $431,674 in stock

General T3NMRA

Seeking Alpha 2mo ago

Neumora Therapeutics GAAP EPS of -$0.23 beats by $0.01

Earnings T2NMRA

Yahoo Finance 4mo ago

Why Neumora Therapeutics (NMRA) Faces a Major Catalyst From Navacaprant’s Upcoming Depression Data

General T2NMRA

Investing.com 4mo ago

Neumora stock price target cut to $7 on failed trial, H.C. Wainwright maintains buy

General T3NMRA

Yahoo Finance 4mo ago

Neumora depression drug fails; EnGene to cut 50% of staff

General T2ENGN NMRA

Seeking Alpha 4mo ago

Neumora plummets as phase 3 navacaprant data misses key goal

General T2NMRA

NMRA news alerts

Get an alert by email or push when a new headline mentions NMRA.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.